The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Cardinal Health’s planned acquisition of Advanced Diabetes Supply Group for $1.1 billion marries its logistics and ...
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Balancing your blood sugar and reducing the risk of health issues can be a challenge for people with diabetes when a cold or ...
And the following 10 monsters have the best chances of appearing in the sequel to Godzilla Minus One. Despite the flashy monster battles and cool CGI, the Godzilla movies have always tried to ...
After bringing the monstrously successful and critically-acclaimed Godzilla Minus One to the screen, Takashi Yamazaki is set to return as writer, director, and VFX supervisor on the next Japanese ...
“Godzilla Minus One” had its world premiere last October 18 in Japan at the Shinjuku Toho Building in Tokyo before opening in Japanese theaters on November 3, 2023 to celebrate the franchise’s 70th ...
By Patrick Brzeski Asia Bureau Chief Good news, kaiju fans: Godzilla will be stomping back into cinemas soon, courtesy of the director behind last year’s Oscar-winning smash hit, Godzilla Minus ...
Takashi Yamazaki, who wrote, directed, and oversaw the VFX for Godzilla Minus One, revealed today in a brief video teaser that his team has been greenlit to work on a second Godzilla.
(AP Photo/Ahn Young-joon) SEOUL, South Korea (AP) — Samsung Electronics on Thursday reported progress on a major supply deal for artificial intelligence-focused chips, aiming to reassure investors ...
Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...
On TikTok recently, you may have seen that blue, embryonic monster from Courage the Cowardly Dog, the one who looks hauntingly at the camera and utters, "You're not perfect…" Weirdly, you've also ...